Establishing associations of thrombospondin linked to tumor growth, with thrombosis

An intriguing fresh insights was obtained from the examination of non-lymphocytic immune cells from a human stage IA lung adenocarcinoma using parallel single-cell RNA-seq (MARS-Seq). HISAT2 was used to align the data to the reference human genome hg38 and perform analysis after the data quality was checked. Thrombospondin was shown to be significantly elevated among the genes particularly expressed in tumour samples by statistical analysis of RNA-seq data. Additional correlation analysis revealed favourable associations with genes such as 5-hydroxytryptamine receptor 6 and G protein-coupled receptor 153. Further, functional protein network analysis of thrombospondin, identified relationships that were predicted, including CD47, CD36 and fibronectin. These partners were divided into three clusters by KMeans clustering, which offered an understanding of Thrombospondin's interactome. It is known that CD36, the thrombospondin receptor, connects to the small GTPase RAP1 and functions in multiple ways in lipid uptake, platelet hyperactivity, and thrombosis. Cell adhesion, migration, and integrin activation were all impacted by the downstream route from CD36 to RAP1 activation, which included ligand binding, intracellular signalling, and RAP1-mediated effects. The analysis identified the significance of functional interaction between Thrombospondin and Rap1 activation which correlates tumor to thrombotic events.